Dr Reddy's Laboratories gains on the bourses

16 Jun 2021 Evaluate

Dr. Reddys Laboratories is currently trading at Rs. 5423.95, up by 9.05 points or 0.17% from its previous closing of Rs. 5414.90 on the BSE.

The scrip opened at Rs. 5372.95 and has touched a high and low of Rs. 5457.35 and Rs. 5343.90 respectively. So far 55977 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 5514.65 on 21-Sep-2020 and a 52 week low of Rs. 3815.80 on 07-Jul-2020.

Last one week high and low of the scrip stood at Rs. 5514.00 and Rs. 5226.00 respectively. The current market cap of the company is Rs. 90358.23 crore.

The promoters holding in the company stood at 26.74%, while Institutions and Non-Institutions held 43.93% and 17.06% respectively.

Dr Reddy's Laboratories has been asked to pay $46.25 million (around Rs 339 crore) to Australia-based Hatchtech Pty as part of an asset purchase agreement between the two parties in 2015.

The company is in receipt of an arbitration award issued by the US-based International Center for Dispute Resolution whereby a subsidiary has been asked to pay an amount of $46.25 million towards milestones, interest and fees to Hatchtech.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1270.75 -8.25 (-0.65%)
17-Dec-2025 11:15 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1776.60
Dr. Reddys Lab 1270.75
Cipla 1493.40
Zydus Lifesciences 917.40
Lupin 2105.70
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×